251 related articles for article (PubMed ID: 29782995)
1. Efficacy of antipsychotics in dementia depended on the definition of patients and outcomes: a meta-epidemiological study.
Smeets CHW; Zuidema SU; Hulshof TA; Smalbrugge M; Gerritsen DL; Koopmans RTCM; Luijendijk HJ
J Clin Epidemiol; 2018 Sep; 101():17-27. PubMed ID: 29782995
[TBL] [Abstract][Full Text] [Related]
2. Management of aggression, agitation, and psychosis in dementia: focus on atypical antipsychotics.
Aupperle P
Am J Alzheimers Dis Other Demen; 2006; 21(2):101-8. PubMed ID: 16634465
[TBL] [Abstract][Full Text] [Related]
3. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological treatment of psychosis and agitation in elderly patients with dementia: four decades of experience.
Kindermann SS; Dolder CR; Bailey A; Katz IR; Jeste DV
Drugs Aging; 2002; 19(4):257-76. PubMed ID: 12038878
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotic treatment of psychosis and agitation in the elderly.
Daniel DG
J Clin Psychiatry; 2000; 61 Suppl 14():49-52. PubMed ID: 11154017
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.
Ballard C; Waite J
Cochrane Database Syst Rev; 2006 Jan; (1):CD003476. PubMed ID: 16437455
[TBL] [Abstract][Full Text] [Related]
7. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
[TBL] [Abstract][Full Text] [Related]
8. A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia.
Pollock BG; Mulsant BH; Rosen J; Mazumdar S; Blakesley RE; Houck PR; Huber KA
Am J Geriatr Psychiatry; 2007 Nov; 15(11):942-52. PubMed ID: 17846102
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotic use in dementia: the relationship between neuropsychiatric symptom profiles and adverse outcomes.
Mueller C; John C; Perera G; Aarsland D; Ballard C; Stewart R
Eur J Epidemiol; 2021 Jan; 36(1):89-101. PubMed ID: 32415541
[TBL] [Abstract][Full Text] [Related]
10. The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia.
Reus VI; Fochtmann LJ; Eyler AE; Hilty DM; Horvitz-Lennon M; Jibson MD; Lopez OL; Mahoney J; Pasic J; Tan ZS; Wills CD; Rhoads R; Yager J
Am J Psychiatry; 2016 May; 173(5):543-6. PubMed ID: 27133416
[No Abstract] [Full Text] [Related]
11. Treatment strategies for agitation and psychosis in dementia.
Tariot PN
J Clin Psychiatry; 1996; 57 Suppl 14():21-9. PubMed ID: 9024333
[TBL] [Abstract][Full Text] [Related]
12. Antipsychotic drugs for psychosis and agitation in dementia: efficacy, safety, and a possible noradrenergic mechanism of action.
Raskind MA; Wang LY
Int Psychogeriatr; 2014 Jun; 26(6):879-83. PubMed ID: 24703502
[No Abstract] [Full Text] [Related]
13. Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia.
Yohanna D; Cifu AS
JAMA; 2017 Sep; 318(11):1057-1058. PubMed ID: 28975291
[No Abstract] [Full Text] [Related]
14. The efficacy and safety of atypical antipsychotics for the treatment of dementia: a meta-analysis of randomized placebo-controlled trials.
Ma H; Huang Y; Cong Z; Wang Y; Jiang W; Gao S; Zhu G
J Alzheimers Dis; 2014; 42(3):915-37. PubMed ID: 25024323
[TBL] [Abstract][Full Text] [Related]
15. A markov model of the cost effectiveness of olanzapine treatment for agitation and psychosis in Alzheimer's disease.
Kirbach S; Simpson K; Nietert PJ; Mintzer J
Clin Drug Investig; 2008; 28(5):291-303. PubMed ID: 18407715
[TBL] [Abstract][Full Text] [Related]
16. Benefits and harms of atypical antipsychotics for agitation in adults with dementia.
Farlow MR; Shamliyan TA
Eur Neuropsychopharmacol; 2017 Mar; 27(3):217-231. PubMed ID: 28111239
[TBL] [Abstract][Full Text] [Related]
17. Treatment of acute agitation in psychotic disorders.
Mohr P; Pecenák J; Svestka J; Swingler D; Treuer T
Neuro Endocrinol Lett; 2005 Aug; 26(4):327-35. PubMed ID: 16136016
[TBL] [Abstract][Full Text] [Related]
18. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
19. Dementia update. Pharmacologic management of agitation and psychosis in older demented patients.
Zaraa AS
Geriatrics; 2003 Oct; 58(10):48-50, 52-3. PubMed ID: 14569642
[No Abstract] [Full Text] [Related]
20. Risperidone for the treatment of behavioral and psychological symptoms of dementia.
Tune LE
J Clin Psychiatry; 2001; 62 Suppl 21():29-32. PubMed ID: 11584986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
